Dropless Pars Plana Vitrectomy Using Intravitreal Decanted Triamcinolone and Moxifloxacin: Safety and Efficacy.

The dropless group demonstrated significantly less anterior chamber inflammation at week 2 (P = 0.0008) and at month 3 (P = 0.0223).

Mean central subfield thickness was lower at week 2 (P = 0.001), month 3 (P = 0.0009), and month 6 (P = 0.012).

Cystoid macular edema incidence was reduced (P < 0.001).

IOP was similar between groups, and no endophthalmitis occurred.